ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

May 21, 1982

Bioassay Backlog Reports show Increasing Number Of Equivocal Results; Is The Program A Failure?

September 2, 1977

Researchers Call For New Approach To Peripheral Neuropathy Testing

February 24, 2012

NCI To Fund Study of Stomach Cancer In Poles, Polish Americans, In Warsaw And Chicago Areas

April 17, 1992

Promising Areas Of Research Listed By NCAB Subcommittee

February 12, 1982

Oxford University Press Wins CRADA For Journal Of The National Cancer Istitute

September 20, 1996